Rivier; Catherine L.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Rivier; Catherine L..The latest application filed is for "gnrh analogs".
- Rivier; Catherine L. - La Jolla CA
- Rivier; Catherine L. - La Jolly CA
| Patent | Date |
|---|---|
| GnRH analogs Grant 5,744,450 - Hoeger , et al. April 28, 1 | 1998-04-28 |
| GNRH antagonists XIII Grant 5,506,207 - Rivier , et al. April 9, 1 | 1996-04-09 |
| Cyclic CRF analogs Grant 5,493,006 - de Miranda , et al. February 20, 1 | 1996-02-20 |
| GnRH analogs Grant 5,296,468 - Hoeger , et al. March 22, 1 | 1994-03-22 |
| CRF antagonists Grant 5,245,009 - Kornreich , et al. * September 14, 1 | 1993-09-14 |
| GnRH analogs Grant 5,169,932 - Hoeger , et al. December 8, 1 | 1992-12-08 |
| Cyclic GnRH antagonists Grant 5,064,939 - Rivier , et al. November 12, 1 | 1991-11-12 |
| Cyclic GRF analogs Grant 5,043,322 - Rivier , et al. August 27, 1 | 1991-08-27 |
| GnRH antagonists IX Grant 4,661,472 - Rivier , et al. April 28, 1 | 1987-04-28 |
| CRF antagonists Grant 4,605,642 - Rivier , et al. August 12, 1 | 1986-08-12 |
| Treatment of male mammals Grant 4,489,061 - Rivier , et al. * December 18, 1 | 1984-12-18 |
| CRF And analogs Grant 4,415,558 - Vale, Jr. , et al. November 15, 1 | 1983-11-15 |
| Contraceptive treatment of male mammals Grant 4,377,574 - Rivier , et al. March 22, 1 | 1983-03-22 |
| LRF Antagonists Grant 4,307,083 - Rivier , et al. December 22, 1 | 1981-12-22 |
| Peptides which inhibit gonadal function Grant 4,215,038 - Rivier , et al. July 29, 1 | 1980-07-29 |
| NCAGE Code | 4P5M2 | RIVIER CATHERINE L |
| CAGE Code | 4P5M2 | RIVIER, CATHERINE L |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 